752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial.
Saved in:
| Title: | 752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial. |
|---|---|
| Authors: | Le Saux, O.1 (AUTHOR), Borel, C.2 (AUTHOR), Ghiringhelli, F.3 (AUTHOR), Bigot, F.4 (AUTHOR), Vansteene, D.5 (AUTHOR), Chaltiel, R.6 (AUTHOR), Cousin, S.7 (AUTHOR), Durando, X.8 (AUTHOR), Coquan, E.9 (AUTHOR), Abdeddaim, C.10 (AUTHOR), Jeannot, E.11 (AUTHOR), Guerini Rocco, E.12 (AUTHOR), Frige, G.13 (AUTHOR), Francisco, M.14 (AUTHOR), Halladjian, M.14 (AUTHOR), Kamal, M.15 (AUTHOR), Legrand, F.16 (AUTHOR), Jimenez, M.16 (AUTHOR), Cabarrou, B.17 (AUTHOR), Le Tourneau, C.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS515-S516. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.1931 |
